MAGBIOVIN / FP7 – ERAChairs – Pilot Call – 2013

The Vinca Institute is among the first eleven institutions in Europe to obtain a grant for the FP7-ERA Chairs project More ». “ERA Chairs” is a new measure under Horizon 2020 to bridge the research and innovation divide with the aim to unlock and develop the Research Potential of research institutions in the EU’s Convergence regions.

The Vinca’s granted project “Strengthening of the MagBioVin Research and Innovation Team for Development of Novel Approaches for Tumour Therapy based on Nanostructured Materials” is focused on the application of activated magnetic nanoparticles in biomedicine. Through the MagBioVin project, the Institute of Nuclear Sciences “Vinca” receives important community support to upgrade its capacities related to the highly specialized research on activated magnetic nanoparticles (MNP) and radionuclide labeled magnetic nanoparticles for application in biosciences, pharmacy and medicine.

This is planned to be realized by a set of comprehensive actions, such as engagement of eminent expert in the field, recruitment of several experienced scientists (Open Call>), bringing experimental facilities up to the most advanced EU-competitive level, cutting-edge trainings in reputable EU research institutions and intensive dissemination towards ERA, Universities and stakeholders. The Project foresees the key role of ERA Chair holder in improvement of organizational structure, research excellence and especially in communication with stakeholders.

Organization of seven dedicated international workshops led by EU experts in the field, six extensive training programs for MagBioVin team members and the accent on intensified international collaboration, are few of the activities anticipated through Project implementation. These are designed to set solid foundations for a final goal: to rise both human and experimental capacities of the “Vinca” Institute to the level that ensures considerable scientific and technological impact within ERA and its ability to compete with leading EU research institutions on an equal basis.